Psychosis
📧 Sign up to get email alerts when something new happens for Psychosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-02-05Clinical Trial Update: Effects of Aerobic Exercise, Cognitive Remediation and Combined Intervention in Schizophrenia [NA]
This clinical trial update notes the completion of a study evaluating aerobic exercise, cognitive remediation, and a combined intervention i…
-
CLINICAL_TRIALS research · 2025-02-04Clinical Trial Update: Investigating the Effect of a Single-dose of Levetiracetam on Brain Function, Chemistry and Cognitive Performance in Psychosis Risk [NA]
A clinical trial update investigates the effects of a single-dose levetiracetam on brain function, brain chemistry, and cognitive performanc…
-
CLINICAL_TRIALS research · 2025-01-24Clinical Trial Update: The Fragility of Metaphors (FraMe): Learning, Loosing, and How to Train Them
A clinical trial update from IRCCS San Raffaele indicating the FraMe study for schizophrenia and psychosis is currently enrolling by invitat…
-
FDA label_change · 2025-01-22FDA Approved: HALOPERIDOL — Supplemental Application (Zydus Lifesciences Limited)
The FDA approved a supplemental labeling application for HALOPERIDOL from Zydus Lifesciences Limited, updating the existing product labeling…
-
FDA approval · 2025-01-22FDA Approved: HALOPERIDOL — Supplemental Application (Lannett Company, Inc.)
The FDA approved a supplemental application for HALOPERIDOL submitted by Lannett Company, Inc., authorizing changes to the product's approva…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2025-01-16FDA Approved: HALOPERIDOL LACTATE — Supplemental Application (Mylan Institutional LLC)
FDA granted a supplemental approval for HALOPERIDOL LACTATE to Mylan Institutional LLC, issuing a supplemental application for this generic …
-
FDA approval · 2025-01-13FDA Approved: HALOPERIDOL — Supplemental Application (Fresenius Kabi USA, LLC)
FDA approved a supplemental application for HALOPERIDOL LACTATE, a generic injectable form of haloperidol from Fresenius Kabi USA, LLC.
-
CLINICAL_TRIALS withdrawal · 2024-12-24Clinical Trial Update: Targeted Intervention Study of DTMS on Impaired Insight in Early Psychosis [NA]
A clinical trial evaluating targeted deep transcranial magnetic stimulation (DTMS) for impaired insight in early psychosis has been withdraw…
-
CLINICAL_TRIALS research · 2024-12-12Clinical Trial Update: Culturally Adapted Psychosocial Interventions for Early Psychosis in a Low-resource Setting [NA]
A clinical trial is evaluating culturally adapted psychosocial interventions for early psychosis in a low-resource setting and is currently …
-
CLINICAL_TRIALS research · 2024-12-11Clinical Trial Update: A Probiotic Strategy for Antipsychotic-induced Metabolic Dysfunction [NA]
A clinical trial is evaluating a probiotic approach to address metabolic dysfunction caused by antipsychotic treatment in psychosis; recruit…
-
CLINICAL_TRIALS trial_result · 2024-12-09Clinical Trial Update: A Study to Assess Efficacy and Safety of KarXT in Acutely Psychotic Hospitalized Adult Patients With Schizophrenia (EMERGENT-3) [Phase 3]
The Phase 3 EMERGENT-3 trial evaluating KarXT in acutely psychotic hospitalized adults with schizophrenia has completed and results were pos…
-
CLINICAL_TRIALS withdrawal · 2024-12-09Clinical Trial Update: The Sub-Sero Study [Phase 2]
Phase 2 trial titled 'The Sub-Sero Study' sponsored by Bjorn H. Ebdrup has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2024-12-05Clinical Trial Update: KF2022#3-trial: Effect of Tea and Cola Beverage on Absorption of Risperidone Oral Solution [Phase 1]
Phase 1 study assessing whether tea and cola beverages affect the absorption of risperidone oral solution in individuals with psychosis; the…
-
CLINICAL_TRIALS research · 2024-11-29Clinical Trial Update: E-Detection Tool for Emerging Mental Disorders
A clinical trial from King's College London is recruiting participants to evaluate an electronic detection tool for emerging mental disorder…
-
CLINICAL_TRIALS research · 2024-11-25Clinical Trial Update: Effects of Online Metacognitive Training Group on Distressing Beliefs [NA]
Clinical trial evaluating online metacognitive training for distressing beliefs in psychosis; currently recruiting.
-
CLINICAL_TRIALS trial_result · 2024-11-21Clinical Trial Update: Effects of Music Beat on Motor Function in Individuals At Risk for Psychotic Onset and Schizophrenia Patients [NA]
A completed clinical trial evaluated the effects of music beat on motor function in individuals at risk for psychotic onset and in schizophr…
-
CLINICAL_TRIALS research · 2024-11-19Clinical Trial Update: Brain Circuitry Therapeutics for Schizophrenia [NA]
Clinical trial update indicating that a schizophrenia-focused brain circuitry therapy is currently recruiting; no results reported.
-
CLINICAL_TRIALS research · 2024-11-14Clinical Trial Update: Multiomic Diagnostics in Youth With Psychosis [NA]
A clinical trial is currently recruiting youth with psychosis to evaluate multiomic diagnostics approaches.
-
CLINICAL_TRIALS trial_result · 2024-11-13Clinical Trial Update: Service User and Staff Views on Digital Remote Monitoring for Psychosis
A completed clinical trial update reporting on the views of service users and staff regarding digital remote monitoring for psychosis.
-
CLINICAL_TRIALS research · 2024-11-08Clinical Trial Update: The ATP Project (Antipsychotic-TEP-Psychosis)
Clinical trial update for The ATP Project investigating antipsychotic treatment in first episode psychosis; the study is not yet recruiting.
-
CLINICAL_TRIALS withdrawal · 2024-10-09Clinical Trial Update: Cognitive Behavioural Therapy-Informed Groups for Psychosis [NA]
The clinical trial evaluating Cognitive Behavioural Therapy–informed groups for psychosis has been withdrawn from the registry.
-
CLINICAL_TRIALS research · 2024-09-26Clinical Trial Update: Semantic and Syntactic Computerized Analysis of Free Speech
A clinical trial is evaluating computerized semantic and syntactic analysis of free speech to study psychotic disorders, including schizophr…
-
CLINICAL_TRIALS trial_result · 2024-09-23Clinical Trial Update: Aspirin in Young Psychotic Patients [Phase 2, Phase 3]
A Phase 2/Phase 3 trial evaluating aspirin in young patients with psychosis has completed and results have been posted.
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: The Personalized Psychological Treatment for Psychosis [NA]
This clinical trial update describes the Personalized Psychological Treatment for Psychosis study, a non-pharmacologic intervention for schi…
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: Evaluating the Effects of Adjunctive Aripiprazole on Weight and Metabolic Outcomes in Females [Phase 4]
Phase 4 clinical trial evaluating adjunctive aripiprazole for weight and metabolic outcomes in women with psychosis and metabolic syndrome. …